Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Evaluation of [14C] and [13C]Sucrose as Blood-Brain Barrier Permeability Markers.

Miah MK, Chowdhury EA, Bickel U, Mehvar R.

J Pharm Sci. 2017 Feb 24. pii: S0022-3549(17)30083-7. doi: 10.1016/j.xphs.2017.02.011. [Epub ahead of print]

PMID:
28238901
2.

Preparation and preliminary characterization of recombinant neurolysin for in vivo studies.

Wangler NJ, Jayaraman S, Zhu R, Mechref Y, Abbruscato TJ, Bickel U, Karamyan VT.

J Biotechnol. 2016 Sep 20;234:105-15. doi: 10.1016/j.jbiotec.2016.07.007. Epub 2016 Aug 2.

PMID:
27496565
3.

Development and validation of a sensitive UPLC-MS/MS method for the quantitation of [(13)C]sucrose in rat plasma, blood, and brain: Its application to the measurement of blood-brain barrier permeability.

Miah MK, Bickel U, Mehvar R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Mar 15;1015-1016:105-10. doi: 10.1016/j.jchromb.2016.02.017. Epub 2016 Feb 16.

PMID:
26919445
4.

Effects of Pringle maneuver and partial hepatectomy on the pharmacokinetics and blood-brain barrier permeability of sodium fluorescein in rats.

Miah MK, Shaik IH, Bickel U, Mehvar R.

Brain Res. 2015 Aug 27;1618:249-60. doi: 10.1016/j.brainres.2015.05.038. Epub 2015 Jun 5.

5.

Transferrin receptor mediated brain uptake during ischemia and reperfusion.

Hao J, Bickel U.

J Pharm Pharm Sci. 2013;16(4):541-50.

6.
7.

Effects of short-term portacaval anastomosis on the peripheral and brain disposition of the blood-brain barrier permeability marker sodium fluorescein in rats.

Shaik IH, Miah MK, Bickel U, Mehvar R.

Brain Res. 2013 Sep 19;1531:84-93. doi: 10.1016/j.brainres.2013.07.040. Epub 2013 Jul 31.

8.

Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique.

Ko YT, Bickel U.

AAPS PharmSciTech. 2012 Jun;13(2):373-8. doi: 10.1208/s12249-012-9757-8. Epub 2012 Feb 11.

9.

Polyethylenimine/oligonucleotide polyplexes investigated by fluorescence resonance energy transfer and fluorescence anisotropy.

Ko YT, Bickel U, Huang J.

Oligonucleotides. 2011 Mar-Apr;21(2):109-14. doi: 10.1089/oli.2010.0271. Epub 2011 Mar 21.

10.

Unifying the mathematical modeling of in vivo and in vitro microdialysis.

Bungay PM, Sumbria RK, Bickel U.

J Pharm Biomed Anal. 2011 Apr 28;55(1):54-63. doi: 10.1016/j.jpba.2011.01.005. Epub 2011 Jan 19.

11.

TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.

Verma B, Jain R, Caseltine S, Rennels A, Bhattacharya R, Markiewski MM, Rawat A, Neethling F, Bickel U, Weidanz JA.

J Immunol. 2011 Mar 1;186(5):3265-76. doi: 10.4049/jimmunol.1002376. Epub 2011 Jan 31.

12.

Acute depression of energy metabolism after microdialysis probe implantation is distinct from ischemia-induced changes in mouse brain.

Sumbria RK, Klein J, Bickel U.

Neurochem Res. 2011 Jan;36(1):109-16. doi: 10.1007/s11064-010-0276-2. Epub 2010 Sep 28.

PMID:
20878232
13.

A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.

Bhattacharya R, Xu Y, Rahman MA, Couraud PO, Romero IA, Weksler BB, Weidanz JA, Bickel U.

J Cell Physiol. 2010 Nov;225(3):664-72. doi: 10.1002/jcp.22256.

14.

Delivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approach.

Pillai VC, Yesudas R, Shaik IH, Thekkumkara TJ, Bickel U, Srivenugopal KS, Mehvar R.

Bioconjug Chem. 2010 Feb 17;21(2):203-7. doi: 10.1021/bc900449b.

PMID:
20063878
15.

Metabolic and transmitter changes in core and penumbra after middle cerebral artery occlusion in mice.

Kiewert C, Mdzinarishvili A, Hartmann J, Bickel U, Klein J.

Brain Res. 2010 Feb 2;1312:101-7. doi: 10.1016/j.brainres.2009.11.068. Epub 2009 Dec 2.

16.

Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions.

Paulson JR, Yang T, Selvaraj PK, Mdzinarishvili A, Van der Schyf CJ, Klein J, Bickel U, Abbruscato TJ.

J Pharmacol Exp Ther. 2010 Feb;332(2):371-9. doi: 10.1124/jpet.109.157776. Epub 2009 Nov 4.

17.

Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.

Ko YT, Bhattacharya R, Bickel U.

J Control Release. 2009 Feb 10;133(3):230-7. doi: 10.1016/j.jconrel.2008.10.013. Epub 2008 Oct 26.

PMID:
19013203
18.

Neuroprotection in mice by NGP1-01 after transient focal brain ischemia.

Hao J, Mdzinarishvili A, Abbruscato TJ, Klein J, Geldenhuys WJ, Van der Schyf CJ, Bickel U.

Brain Res. 2008 Feb 27;1196:113-20. doi: 10.1016/j.brainres.2007.11.075. Epub 2008 Jan 29.

PMID:
18234166
19.

Bap29varP, a variant of Bap29, influences the cell surface expression of the human P-glycoprotein.

Rao PS, Bickel U, Srivenugopal KS, Rao US.

Int J Oncol. 2008 Jan;32(1):135-44.

PMID:
18097552
20.

Targeted delivery of complexes of biotin-PEG-polyethylenimine and NF-kappaB decoys to brain-derived endothelial cells in vitro.

Bhattacharya R, Osburg B, Fischer D, Bickel U.

Pharm Res. 2008 Mar;25(3):605-15. Epub 2007 Oct 20.

PMID:
17952570

Supplemental Content

Loading ...
Support Center